Jeremy Hobson: We’re getting a look at the health of the pharmaceutical industry today with earnings from companies like Johnson & Johnson, and Forest Laboratories. Analysts are seeing a bit of a downer from the drug companies this quarter.
Marketplace’s Jennifer Collins reports.
Jennifer Collins: Patents are about to expire on several blockbusters: Plavix, Zyprexa and cholesterol drug Lipitor. That last one is the bestselling drug in the world.
Lipitor advertisement: I trust my heart to Lipitor.
But millions of people may start trusting their hearts to generics once Pfizer loses that patent.
Chris Bowe: Thus they meet what they call a patent cliff.
Analyst Chris Bowe says Pfizer’s sales of Lipitor could drop by half in as little as a year. So Pfizer and other pharmaceutical companies need to have a stream of drugs in development. Miller Tabak’s Les Funtleyer says, these days, there’s been a shortage.
Les Funtleyder: Drugs are going generic faster than pharmaceutical companies can create new ones.
So what they can’t create, they buy.
Funtleyder: Which is why you’ve seen a lot of acquisitions.
And Funtleyder says that is likely to continue.
I’m Jennifer Collins for Marketplace.
We’re here to help you navigate this changed world and economy.
Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.
In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.
Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.